| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |